Back to results
US 8,044,041 B2Granted
Phthalazine derivatives as inhibitors of protein kinase
AssigneeForest Laboratories Holdings Limited
InventorsGian-Luca Araldi, Matthew Ronsheim, Melanie Ronsheim
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel phthalazine derivatives and, more particularly, to phthalazine derivatives of formula (III) that are useful as protein kinase inhibitors. The invention also relates to methods of preparing the compounds, compositions containing the compounds, and methods of treatment using the compounds.
Claims32
A compound of formula III:
- wherein
- X is hydrogen, halogen, alkyl, aryl, heteroaryl, cyano or alkoxy;
- R′ is hydrogen, alkyl, —C(O)Rx, —SO2Rx or —P(O)(ORx)2, where Rx is hydrogen or alkyl;
- R11 and R12 are each independently hydrogen, halogen, hydroxy, cyano, amino, alkyl, alkenyl, alkynyl, heterocyclyl, alkoxy, alkythio, arylthio, -alkylene-NRaRb, C(O)Ra, —C(O)NRaRb, -alkylene-C(O)NRaRb, —C(O)ORa, —C(S)NRaRb, —C(S)Ra, —C(O)SRa, NO2, NH2, —NRaC(O)Rb, —NRaRb, —NRaORb, —NRaC(S)Rb, —NRaC(O)NRbRc, —NRaC(S)NRbRc, —NRa(COORb), —NRaS(O)2NRbRc, —NRaS(O)Rb, —NRaS(O)2Rb, —ORa, —OC(O)Ra, —ONRaRb, —OC(O)NRaRb, —SRa, —S(O)2Ra, or —S(O)2NRaRb, wherein Ra, Rb and Rc are each independently hydrogen, hydroxy, cyano, nitro, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, alkylaryl, haloaryl, heteroaryl, alkylheteroaryl, alkylheterocyclyl, alkoxy, alkythio, arylthio, or alkoxycarbonyl, wherein, if present, an aryl, alkylaryl, heteroaryl, alkylheteroaryl, heterocyclyl, or alkylheterocycyl may be substituted, in one or more positions with a substituent or a combination of substituents selected from halogen, hydroxy, cyano, nitro, amino, carboxyl, alkyl, alkenyl, alkynyl, alkoxy, alkylamino, alkylthio, —C(O)NRd-alkylheterocyclyl (in which Rd is H or alkyl), O-alkylheterocyclyl, alkylheterocyclyl, aryl, heteroaryl, heterocyclyl, aryloxy, alkylamino, dialkylamino, aminoalkyl, -alkylene-O-alkyl, —NReC(O)Rf, —NRe(alkylene-NReRf), —NRe(alkylheterocyclyl), and —O-alkylene-NReRf (in which Re and Rf are independently hydrogen or alkyl;
- wherein at least one of R11 or R12 is -alkylene-C(O)NRaRb, -alkylene-NRaRb, —C(O)NRaRb, —NRaC(O)Rb or —NRaRb;
- and pharmaceutically acceptable salts thereof,
- provided that said compound is not:
- N-(3,4-dihydro-4-oxo-6-phthalazinyl)-2-methyl-2-propenamide,
- N-(1,2-dihydro-1-oxo-6-phthalazinyl)-2-methyl-2-propenamide,
- 7-(cyclohexylamino)-6-(phenylamino)-1(2H)-phthalazinone,
- 6,7-bis(phenylamino)-1(2H)-phthalazinone,
- 6-amino-7-chloro-1(2H)-phthalazinone,
- or a pharmaceutically acceptable salt thereof.
10 more elements
A compound of formula IV:
- wherein
- R13 is hydrogen, halogen, alkyl, aryl, heteroaryl, cyano or alkoxy;
- R14 is hydrogen, alkyl, —C(O)Ry, —SO2Ry or —P(O)(ORy)2, where Ry is hydrogen or alkyl;
- and
- R15 is hydrogen, alkyl, aryl, heteroaryl, heterocyclyl, alkylaryl, alkylheteraryl, alkylheterocyclyl or aminoalkyl;
- wherein an aryl, heteroaryl, heterocyclyl, alkylaryl, alkylheteraryl, alkylheterocyclyl may be optionally substituted by halogen, alkyl, alkenyl, alkynyl, cyano, nitro, amino, alkylamino, dialkylamino, hydroxyl, carboxyl, aryl, heteroaryl, heterocyclyl, alkylaryl, alkylheteroaryl, alkylheterocyclyl, alkylalkoxy, or NRx(alkylheterocyclyl) where Rx is hydrogen or alkyl.
3 more elements
Dependencies are inferred from the claim text.